Clinical Trials Browser

Phase 1/2 × Amyloidosis × Lisaftoclax × Clear all

NCT04942067 2023-10-25

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

Amyloidosis, Multiple Myeloma